NEW YORK, NY / ACCESSWIRE / July 13, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
CytomX Therapeutics, Inc. (NASDAQ: CTMX)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=7896&wire=1
Lead Plaintiff Deadline: July 20, 2020
Class Period: May 17, 2018 - May 13, 2020
Allegations against CTMX include that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
J2 Global, Inc. (NASDAQ: JCOM)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/j2-global-inc-loss-submission-form?prid=7896&wire=1
Lead Plaintiff Deadline: September 8, 2020
Class Period: October 5, 2015 - June 29, 2020
Allegations against JCOM include that: (1) J2 Global engaged in undisclosed related party transactions; (2) J2 Global used misleading accounting to hide requisite impairments and underperformance in acquisitions; (3) several so-called independent members of the Company' board of directors and audit committee were not disinterested; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
Wirecard AG (OTC PINK: WRCDF)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/wirecard-ag-loss-submission-form-2?prid=7896&wire=1
Lead Plaintiff Deadline: September 8, 2020
Class Period: August 17, 2015 - June 24, 2020
Allegations against WRCDF include that: (1) Wirecard overstated its cash balances during the Class Period, falsely claiming €1.9 billion of cash in a trust account that was missing; (2) Wirecard overstated its financial results during the Class Period, including revenue and EBITDA; (3) Wirecard did not have adequate risk management or countermeasures; (4) the Company's external auditor failed to audit Wirecard in accordance with applicable auditing principles; and (5) as a result, Defendants' statements about Wirecard's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE: The Law Offices of Vincent Wong